麻酔後のケアユニットにおける高齢者のサブシンドロマの妄想を予測するためのノモグラムとリスクの階層化:前向きなコホート研究
Guoting Ma1, Wenjun Yan1, Qian Yang2
1Department of Anesthesiology, Gansu Provincial Hospital, No.204 Donggang West Road, Lanzhou 730000, China.
International journal of nursing studies advances
|August 20, 2025
まとめ
この研究では,高齢者のサブシンドロームの妄想を予測するノモグラムを開発し,主要な危険因子を特定しました. このモデルは効果的に患者を層分けし 早期の介入により よりよい術後の結果が得られます
科学分野:
- 高齢者医療
- 麻酔科
- クリティカル ケア 医療
背景:
- サブシンドロームの妄想は 術後の高齢者のリスクです
- 早期発見は有害な結果を防ぐために重要です
研究 の 目的:
- サブシンドロームのリスク予測モデルを開発する.
- 麻酔後のケアユニットにおけるサブシンドロームの予測要因を特定する.
主な方法:
- 2636人の高齢者を対象とした前向きなコホート研究.
- 混乱の評価方法を使用した.
- ノモグラムモデルを構築するために LASSOとロジスティック回帰を使用した.
主要な成果:
- サブシンドローム性妄想の発生率は18. 6%でした.
- 特定された危険因子:年齢,中性粒子のリンパ球比,夜間手術,低体温,PCA,換気期間.
- ノモグラムは優れた予測性能を示した (AUC 0. 904 訓練,0. 850 検証).
結論:
- ノモグラムは,サブシンドローム性妄想症の高リスク患者を効果的に特定します.
- 手術後の回復を改善するための標的型介入におけるリスク分層化補助剤
さらに関連する動画
関連する概念動画
Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
861
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
861
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
400
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367


